Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
Status:
Unknown status
Trial end date:
2020-06-20
Target enrollment:
Participant gender:
Summary
This will be a multi-site, open-label, randomized clinical trial. The investigators will
randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that
are to be followed when using a contraceptive vaginal ring delivering a daily dose of
Nestorone® and estradiol (NES-E2 CVR).
Phase:
Phase 2
Details
Lead Sponsor:
Health Decisions
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Population Council